Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Praga

Showing results (41-50 of 265) with videos related to

Pageof 27
Sort By:
Current Pharmaceutical Design|April 28, 2005
The reno-protective effect of the dual blockade of the renin angiotensin system (RAS)José Luno, Manuel Praga, Soledad García de Vinuesa
Transplant International : Official Journal of the European Society for Organ Transplantation|February 26, 2015
A case of thrombotic micro-angiopathy after heart transplantation successfully treated with eculizumabEnrique Morales, Cristina Rabasco, Eduardo Gutierrez, et al.
Kidney International|October 26, 2019
The authors replyTeresa Cavero, Santiago Rodríguez de Córdoba, Manuel Praga
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 18, 2014
Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injuryManuel Praga, Angel Sevillano, Pilar Auñón, et al.
Current Hypertension Reports|March 23, 2013
Guidelines updates in the treatment of obesity or metabolic syndrome and hypertensionCésar Cerezo, Julian Segura, Manuel Praga, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 29, 2021
Contribution of a histologic index to the prognostic information of C3 glomerulopathyFernando Caravaca-Fontán, Hernando Trujillo, Francisco Caravaca, et al.
Nephron|May 6, 2020
Update on C3 Glomerulopathy: A Complement-Mediated DiseaseFernando Caravaca-Fontán, Laura Lucientes, Teresa Cavero, et al.
Journal of the American Society of Nephrology : JASN|May 23, 2003
Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trialManuel Praga, Eduardo Gutiérrez, Ester González, et al.
Clinical Kidney Journal|December 6, 2023
Targeting complement in IgA nephropathyFernando Caravaca-Fontán, Eduardo Gutiérrez, Ángel M Sevillano, et al.
Nefrologia|January 13, 2018
Hyperkalemia of non-renal origin in a hemodialysis patientPaola Rodríguez, Evangelina Mérida, Eduardo Hernández, et al.
Pageof 27

Showing results (41-50 of 265) with videos related to

Sort By:
Pageof 27
Current Pharmaceutical Design|April 28, 2005
The reno-protective effect of the dual blockade of the renin angiotensin system (RAS)José Luno, Manuel Praga, Soledad García de Vinuesa
Transplant International : Official Journal of the European Society for Organ Transplantation|February 26, 2015
A case of thrombotic micro-angiopathy after heart transplantation successfully treated with eculizumabEnrique Morales, Cristina Rabasco, Eduardo Gutierrez, et al.
Kidney International|October 26, 2019
The authors replyTeresa Cavero, Santiago Rodríguez de Córdoba, Manuel Praga
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 18, 2014
Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injuryManuel Praga, Angel Sevillano, Pilar Auñón, et al.
Current Hypertension Reports|March 23, 2013
Guidelines updates in the treatment of obesity or metabolic syndrome and hypertensionCésar Cerezo, Julian Segura, Manuel Praga, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 29, 2021
Contribution of a histologic index to the prognostic information of C3 glomerulopathyFernando Caravaca-Fontán, Hernando Trujillo, Francisco Caravaca, et al.
Nephron|May 6, 2020
Update on C3 Glomerulopathy: A Complement-Mediated DiseaseFernando Caravaca-Fontán, Laura Lucientes, Teresa Cavero, et al.
Journal of the American Society of Nephrology : JASN|May 23, 2003
Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trialManuel Praga, Eduardo Gutiérrez, Ester González, et al.
Clinical Kidney Journal|December 6, 2023
Targeting complement in IgA nephropathyFernando Caravaca-Fontán, Eduardo Gutiérrez, Ángel M Sevillano, et al.
Nefrologia|January 13, 2018
Hyperkalemia of non-renal origin in a hemodialysis patientPaola Rodríguez, Evangelina Mérida, Eduardo Hernández, et al.
Pageof 27